Why the human genome could be healthcare’s holy grail
source link: https://finance.yahoo.com/video/why-human-genome-could-healthcare-002054101.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
Why the human genome could be healthcare’s holy grail
Why the human genome could be healthcare’s holy grail
23andMe Co-founder & CEO Anne Wojcicki says we’ve only seen the tip of the iceberg for human genomics and DNA research. “Look at all the explosion of all these new technologies with gene therapy, with CRISPR (CRSP), with RNA technologies and understanding the human genome,” Wojcicki told Yahoo Finance at the Milken Global Conference in Beverly Hills, California. Wojcicki says she’s ‘disappointed’ in the lack of progress around genomics, despite having just crossed a significant milestone, 20 years since the first complete sequencing of the human genome. “I think part of the reason is that genetics tells you a lot about what you're at risk for and it doesn't necessarily financially pay to get you that preventative information and to intervene in that way versus just treating people once they have a disease.” The 23andME (ME) CEO also says they are looking into building new partnerships with pharmaceutical companies once the company’s partnership with GlaxoSmithKline (GSK) ends in July.
Interview Highlights: 1:29 How genetics can tell us more about human diversity 2:20 Why 23andMe CEO is ‘disappointed’ about genome adoption 5:00 Wojcicki on 23andMe partnership with pharma giant GSK 7:15 Genetics needs to be part of medical school training 8:26 What’s next for 23andMe
-
Why the human genome could be healthcare’s holy grail10:14
-
Starbucks earnings: 3 things we’re watching ahead of the Earnings Call
-
CEOs weigh in on banking crisis
-
Hawaiian Airlines is going to see 'better results over the next couple of quarters,' CEO says -
What you need to know about negotiating a severance package
-
First Republic’s collapse: ‘There will be more bank failures,’ analyst
-
Barbie is a 'power brand': Mattel CEO
-
Barbie movie is 'a showcase for the quality of the movies we're looking to make,' Mattel CEO says
-
JPMorgan acquires First Republic, DeSantis-Disney feud escalates, Lordstown Motors' warning
-
We are probably heading for recession: Citi CEO
-
Writers’ Strike looms in Hollywood: What to expect
-
U.S. could hit debt ceiling by June 1 if no deal is reached, Treasury Secretary Yellen warns in new letter
-
JPMorgan 'got the best part of the deal' buying First Republic Bank, analyst says
23andMe Co-founder & CEO Anne Wojcicki says we’ve only seen the tip of the iceberg for human genomics and DNA research.
“Look at all the explosion of all these new technologies with gene therapy, with CRISPR (CRSP), with RNA technologies and understanding the human genome,” Wojcicki told Yahoo Finance at the Milken Global Conference in Beverly Hills, California.
Wojcicki says she’s ‘disappointed’ in the lack of progress around genomics, despite having just crossed a significant milestone, 20 years since the first complete sequencing of the human genome.
“I think part of the reason is that genetics tells you a lot about what you're at risk for and it doesn't necessarily financially pay to get you that preventative information and to intervene in that way versus just treating people once they have a disease.”
The 23andME (ME) CEO also says they are looking into building new partnerships with pharmaceutical companies once the company’s partnership with GlaxoSmithKline (GSK) ends in July.
Interview Highlights:
How genetics can tell us more about human diversity
Why 23andMe CEO is ‘disappointed’ about genome adoption
Wojcicki on 23andMe partnership with pharma giant GSK
Genetics needs to be part of medical school training
What’s next for 23andMe
Video Transcript
BRIAN SOZZI: I'm really interested in what 23 is-- 23andMe is working on at this point in its life. But you have said, you see the world through the lens of genetics. What is this world telling you right now?
ANNE WOJCICKI: Oh. Well, genetics-- so I should say, we're on the 20th anniversary of when the first human genome was sequenced. And it has, you know, it's a big milestone of like when it costs billions of dollars to get a single person sequenced and what you can learn from that to where we are today, where 23andMe has over 13 million people. You can learn a tremendous amount from your genome. And you can start to account for like all of this incredible diversity we see in life and all of the variation we have in our health, and like why some people do so well on a treatment, why some people don't, why some people get a disease, why some people don't.
Yahoo FinanceIMAX CEO: Streaming experiment 'failed' as box office claws back from pandemic lows
IMAX CEO Richard Gelfond is more bullish than ever on the theatrical experience.
14h ago
ZacksUnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
22h ago
BloombergXi’s Food Security Drive Could End Up Backfiring for Chinese Farmers
(Bloomberg) -- After more than 30 years growing crops on the plains of northern China, a farmer who asked to be identified as Zhang is struggling over what to plant in the coming months. Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoMorgan Stanley Plans 3,000 More Job Cuts as Dealmaking SlumpsNigeria Targeted a UK Mansion; Its Next Leader’s Son Now Owns ItPres
8h ago
Yahoo Finance23andMe CEO: We see more opportunities in DNA partnerships
23 & Me CEO Anne Wojicki reveals the next key opportunity for her company.
19h ago
BloombergApple-Masimo Trade Secrets Fight Ends With No Jury Verdict
(Bloomberg) -- Apple Inc. and Masimo Corp. failed to persuade a jury to reach a unanimous verdict in a trial where the medical-devices company claimed a blood-oxygen sensor in the Apple Watch was developed using misappropriated trade secrets.Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoMorgan Stanley Plans 3,000 More Job Cuts as Dealmaking SlumpsNigeria Targe
8h ago
BloombergStocks Wobble on Amped Up Policy-Tightening Bets: Markets Wrap
(Bloomberg) -- European stocks retreated and US equity futures wobbled after Australia’s unexpected interest-rate increase deepened conviction that US and European central banks push ahead with policy tightening to stamp out inflation. Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoMorgan Stanley Plans 3,000 More Job Cuts as Dealmaking SlumpsNigeria Targeted a
56m ago
Business InsiderThe stock market is poised for a sell-off as an overly hawkish Fed could dash hopes for interest rate cuts, Morgan Stanley's Mike Wilson says
"If the message delivered at this meeting is more hawkish, it could provide a near-term negative surprise for equities," Mike Wilson said.
10h ago
Yahoo FinanceDimon: 'This part of the crisis is over'
The CEO of JPMorgan Chase argued the seizure and sale of First Republic puts to rest an excruciating period of panic for the banking system.
20h ago
Yahoo FinanceFDIC proposes Congress increase deposit insurance limits for payroll accounts
The FDIC on Monday outlined three possibilities for the future of deposit insurance, recommending to Congress new rules tailored to increase insured limits for some business accounts.
17h ago
Investor's Business DailyFour Stocks Turn $10,000 Into $50,000 In Four Months
April turned out to be great month for most S&P 500 investors. But it was stupendous for those who picked the best stocks.
23h ago
BloombergFirst Republic’s Jumbo Mortgages Brought On Bank’s Failure
(Bloomberg) -- The seeds of First Republic Bank’s downfall were sown in the jumbo mortgages of Silicon Valley, where a unique strategy to loan wealthy individuals extraordinary sums of money blew up in spectacular fashion.Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoBuffett Will Beat the Market as Recession Looms, Investors SayMorgan Stanley Plans 3,000 More
17h ago
Business InsiderBullish investors are an 'endangered species' on Wall Street as bearish sentiment prevails. That points to big returns ahead for stocks, Bank of America says.
"It has been a bullish signal when Wall Street strategists were extremely bearish, and vice versa," Bank of America said.
12h ago
Yahoo FinanceCiti CEO: The US banking system is strong and safe
Citi CEO Jane Fraser shares her analysis on the state of the banking industry in the wake of JPMorgan's deal for First Republic.
14h ago
Yahoo FinanceStocks muted as JPMorgan Chase takes over First Republic: Stock market news today
Wall Street weighed the news that JPMorgan, the largest bank in the U.S., agreed to assume all of First Republic’s deposits after it was seized by regulators in the biggest bank failure since 2008.
15h ago
Investor's Business DailyNvidia Stock In Buy Zone After Nearly Doubling In 2023 — Is It A Buy?
Nvidia earnings are set to rebound while AI leadership has excited investors in the leading chip stock. Nvidia stock is on a tear.
13h ago
Bankrate6 best money market funds in May 2023
Money market funds are available from several different brokers and fund managers.
17h ago
Barrons.comPfizer Earnings Will Show How Much Covid Is Still Driving Revenue
As Pfize r reports its first quarter financial results on Tuesday morning, the company is looking to shift investor attention to the future: The recent approval of its new pneumococcal vaccine for children, the expected launch this year of its respiratory syncytial virus vaccine, a new treatment for alopecia areata that could hit the market later this year. On Sunday, the Financial Times reported that Pfizer (ticker: PFE) and its partner BioNTech (BNTX) are negotiating a deal to provide 70 million Covid-19 vaccine doses a year to the European Union through 2026. At its last earnings presentation in late January, Pfizer told investors to expect $13.5 billion of Covid-19 vaccine sales in 2023, down from $37.8 billion in 2022.
15h ago
Yahoo FinanceStarbucks earnings preview: US sales growth, China recovery in focus
Starbucks (SBUX) is set to report second quarter fiscal year 2023 earnings results on Tuesday, May 2. Expected: good news for investors.
17h ago
BenzingaPfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Astellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced detailed Phase 3 EMBARK trial data. The companies tested Xtandi plus leuprolide and Xtandi as a monotherapy against placebo plus leuprolide in men with non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence (BCR). The 1,068-patient trial hit the primary endpoint, metastasis-free survival (MFS). The companies released topline data from the study in March this year. Xtandi (enzalutamide) plus leup
14h ago
Barrons.comBud Light Sales Fall 26% as Transgender Backlash Worsens
Bud Light's sales declines accelerated in the week ended April 22, according to Beer Business Daily
16h ago
TipRanks‘Investment opportunity of a lifetime’: Cathie Wood says the robotaxi market could be worth trillions — here are 3 stocks to invest in it (besides Tesla)
Advances in technology often come loaded with financial opportunities and scanning the one presented by the nascent autonomous driving sector, Cathie Wood thinks there is a huge one at play. The Ark Invest CEO has not been shy about making some bold predictions in the past and thinks investors should not underestimate what’s in store for this up-and-coming industry. “We think that the robotaxi opportunity globally will deliver $8 to $10 trillion in revenue by 2030 and is one of the most importan
21h ago
BloombergRivian’s Troubles Don’t End at a 93% Wipeout
(Bloomberg) -- The relentless erosion in Rivian Automotive Inc.’s share price is revealing an ugly truth: Investors have little faith left in the ability of the Amazon.com Inc.-backed company to compete in a crowded electric-vehicle market.Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureRivian’s Troubles Don’t End at a 93% WipeoutBuffett Will Beat the Market as Recession Looms, Investors SayPeak Oil Spells
21h ago
TipRanks3 “Strong Buy” Stocks With Short Squeeze Potential
It might be logical to assume that stocks with heavy short interest – i.e., ones that many investors/traders are essentially betting against – are stocks to stay away from, but that is not always the case. Opinions on the stock market can be varied, and it’s not uncommon to find stocks with both high short interest and positive recommendations from Wall Street analysts. But only one can be right, right? And should the analysts turn out to be the ones to hit the nail on the head, panic-induced sh
10h ago
Yahoo FinanceFirst Republic stock investors face 'wipe-out,' analyst says
JPMorgan did not assume First Republic’s corporate debt or preferred stock, meaning institutional investors will not be a made whole. One analyst expects common shareholders to get wiped out, too.
16h ago
Barrons.comThese Stocks Are Moving the Most Today: Chegg, Arista, BP, BlackBerry, and More
Chegg stock falls sharply after the online-education company says it has been seeing a 'significant spike in student interest in ChatGPT,' while Arista anticipates some of its biggest cloud customers soon could begin cutting back on spending.
1h ago
Yahoo FinanceNew lower I bond rate comes with 'a pleasant surprise'
The annualized yield for the Treasury Department’s inflation-protected assets is 4.3% for new purchases made until October 31.
19h ago
ZacksBig Tech Earnings: Time to Take Another Bite of Apple?
Last week, big tech stole the spotlight, posting results that had the market celebrating and helping keep sentiment lifted heading into this week's FOMC meeting. But what about Apple?
12h ago
AP FinanceBP posts $5B quarterly profit on strong oil and gas trading
British energy giant BP posted a strong quarterly profit on Tuesday even as oil and natural prices that soared after Russia's war in Ukraine last year have eased off. The company said the earnings report "reflects an exceptional gas marketing and trading result” and a “very strong oil trading result.” Oil companies around the world have been reporting bumper earnings in the wake of Russia's invasion of Ukraine in February 2022, which sent energy prices soaring and curtailed some of Moscow's supplies to the world.
48m ago
QuartzWhy did JPMorgan Chase buy First Republic out of receivership?
You can ask why JPMorgan Chase agreed to buy the failed First Republic Bank out of regulatory receivership. But a better question might be, why not? As JPMorgan chairman and CEO Jamie Dimon explained in a company press release: “This acquisition modestly benefits our company overall, it is accretive to shareholders, it helps further advance our wealth strategy, and it is complementary to our existing franchise.”
21h ago
BloombergStock Pickers on Wall Street Are Going All-In on Recession Bets
(Bloomberg) -- As Wall Street economists and central bankers debate if and when the US economy will slip into a recession, big money managers aren’t waiting to find out. Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoMorgan Stanley Plans 3,000 More Job Cuts as Dealmaking SlumpsBuffett Will Beat the Market as Recession Looms, Investors SayIncreasingly, professio
15h ago
Business InsiderStocks could soon retest all-time highs as markets react to possible 'thesis-changing' final rate hike from the Fed, Fundstrat says
"This will likely be the last hike of the cycle. This is thesis changing," Fundstrat said, predicting the S&P 500 could notch 4,750 by year-end.
6h ago
Zacks4 Renewable Energy Stocks Set to Beat Q1 Earnings Estimates
First-quarter earnings of the Zacks Oil-Energy sector, which houses renewable energy stocks, are expected to improve a solid 6.7%. Revenues are likely to decline 6.6%.
20h ago
BloombergTesla’s Rare Earths Shift Propels Rally in Korean Ferrite Stocks
(Bloomberg) -- Two months after Tesla Inc. unveiled plans to drop the usage of rare earths in its future models, ferrite stocks in South Korea are skyrocketing on bets that the material will be an alternative. Most Read from BloombergJPMorgan Ends First Republic’s Turmoil After FDIC SeizureFirst Republic’s Jumbo Mortgages Brought On Bank’s FailureIBM to Pause Hiring for Jobs That AI Could DoMorgan Stanley Plans 3,000 More Job Cuts as Dealmaking SlumpsNigeria Targeted a UK Mansion; Its Next Leade
4h ago
InvestopediaWho Are Charles Schwab's Main Competitors?
Find out who Charles Schwab's main competitors are and how they stack up. Use this information to make informed investing decisions.
21h ago
FX EmpireEUR/USD Forecast – Euro Continues to Grind Sideways
The Euro has gone back and forth during the day on Monday, as we continue to see a lot of hesitation at this extended level.
22h ago
ZacksArista Networks (ANET) Tops Q1 Earnings and Revenue Estimates
Arista Networks (ANET) delivered earnings and revenue surprises of 5.93% and 3.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
13h ago
ZacksCF Industries (CF) Tops Q1 Earnings and Revenue Estimates
CF (CF) delivered earnings and revenue surprises of 8.37% and 6.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
13h ago
ZacksWill Strong Embedded Growth Aid AMD's Q1 Earnings Growth?
AMD's first-quarter 2023 earnings are expected to have been affected by weak PC shipments, offset by robust demand for embedded solutions.
15h ago
Barrons.comBP Earnings Beat Expectations. Why the Stock Is Falling.
The oil major posted underlying profit of $5 billion for the first three months of the year, up from $4.8 billion in the fourth quarter.
12m ago
BloombergAmerican Airlines Could Avoid Pilot Strike
American Airlines Group Inc. and its pilots union are close to reaching an agreement on a new contract after weeks of focused negotiations. Southwest Airlines and United are also in contract talks with the pilots union. Delta reached a new deal. Bloomberg's Mary Schlangenstein reports. Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness/ Instagram: https://www.instagram.com/quicktake/?hl=en
14h ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK